ARTICLE | Clinical News
Meveol hypothiocyanite/lactoferrin regulatory update
September 21, 2009 7:00 AM UTC
The EC granted Orphan Drug designation for Alaxia's Meveol to treat cystic fibrosis. The inhaled combination of hypothiocyanite and lactoferrin, which the company said is designed to deliver natural a...